TY - JOUR
T1 - First characterization of a cluster of VanA-type glycopeptide-resistant Enterococcus faecium, Colombia
AU - Panesso, Diana
AU - Ospina, Sigifredo
AU - Robledo, Jaime
AU - Vela, María Claudia
AU - Peña, Julieta
AU - Hernández, Orville
AU - Reyes, Jinnethe
AU - Arias, César A.
PY - 2002/9
Y1 - 2002/9
N2 - From August 1998 to October 1999, glycopeptide-resistant enterococci (GRE) were isolated from 23 infected patients at a teaching hospital in Medellin, Colombia. Identification at the species level and by multiplex polymerase chain reaction assay indicated that all isolates were Enterococcus faecium. The isolates were highly resistant to ampicillin, ciprofloxacin, gentamicin, penicillin, streptomycin, teicoplanin, and vancomycin; they were susceptible only to chloramphenicol, linezolid, and nitrofurantoin. Determination of glycopeptide genotype indicated the presence of the vanA gene in all isolates. Molecular typing by pulsed field gel electrophoresis showed that all isolates were closely related. This study is the first molecular characterization of GRE in Colombia.
AB - From August 1998 to October 1999, glycopeptide-resistant enterococci (GRE) were isolated from 23 infected patients at a teaching hospital in Medellin, Colombia. Identification at the species level and by multiplex polymerase chain reaction assay indicated that all isolates were Enterococcus faecium. The isolates were highly resistant to ampicillin, ciprofloxacin, gentamicin, penicillin, streptomycin, teicoplanin, and vancomycin; they were susceptible only to chloramphenicol, linezolid, and nitrofurantoin. Determination of glycopeptide genotype indicated the presence of the vanA gene in all isolates. Molecular typing by pulsed field gel electrophoresis showed that all isolates were closely related. This study is the first molecular characterization of GRE in Colombia.
UR - http://www.scopus.com/inward/record.url?scp=0036712929&partnerID=8YFLogxK
U2 - 10.3201/eid0809.010435
DO - 10.3201/eid0809.010435
M3 - Artículo
C2 - 12194774
AN - SCOPUS:0036712929
SN - 1080-6040
VL - 8
SP - 961
EP - 965
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 9
ER -